Related Experiment Video

Updated: May 10, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

Minimal killing unit of the mitochondrial targeting domain of Noxa

Ji-Young Kim1, Ji Hye Han, Ae-Ran Moon

  • 1Department of Biochemistry and Molecular Biology, Chosun University School of Medicine, 309 Pilmoondaero, Gwang-Ju, 501-759, Korea.

Journal of Peptide Science : an Official Publication of the European Peptide Society
|June 25, 2013
PubMed

Insights

Researchers identified the minimal unit of Noxa's mitochondrial-targeting domain (MTD) responsible for cancer cell death. MTD(8) effectively kills tumor cells while sparing normal cells, showing potential for targeted cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Death Mechanisms
  • Cancer Research

Background:

  • Noxa is crucial for p53-mediated apoptosis through mitochondrial dysfunction.
  • The mitochondrial-targeting domain (MTD) of Noxa mediates mitochondrial translocation and necrotic cell death induction.

Purpose of the Study:

  • To determine the minimal functional unit of the MTD responsible for inducing cell death.
  • To evaluate the in vitro and in vivo efficacy of MTD fragments.

Main Methods:

  • Synthesized and tested various MTD peptide fragments (R8:MTD(10), R8:MTD(9), R8:MTD(8), R8:MTD(7)).
  • Assessed cell-killing activity against human tumor cell lines (HCT116, HeLa, MCF-7, BJAB) and normal peritoneal macrophages.
  • Evaluated in vivo tumor suppression in a mouse model (CT26 cell-derived tumors).

Main Results:

  • Peptides R8:MTD(10), R8:MTD(9), and R8:MTD(8) demonstrated significant tumor cell killing.
  • R8:MTD(7) lost killing activity due to impaired mitochondrial targeting.
  • R8:MTD(8) exhibited selective toxicity towards tumor cells over normal macrophages.
  • In vivo studies showed limited tumor growth suppression by R8:MTD(10), R8:MTD(9), and R8:MTD(8).

Conclusions:

  • MTD(8) represents the minimal killing unit of the Noxa MTD.
  • MTD(8) shows potential as a targeted therapeutic agent due to its selective tumor cell toxicity.
Keywords:
Noxaanti-cancerdeleted MTD peptidetumor suppression

More Related Videos

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice08:40

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Protein Transport into the Inner Mitochondrial Membrane01:34

Protein Transport into the Inner Mitochondrial Membrane

Nuclear encoded mitochondrial precursors are imported to the inner membrane in a multistep process involving two separate translocons, TIM22 and TIM23. TIM23 is a cation-selective pore that remains closed by the N terminal segment of the protein. Negative charges on the TIM23 act as a receptor for the incoming precursor, pulling the positively charged matrix-targeting sequence for peptide insertion and translocation.
Transport of mitochondrial precursors across the TIM23 channel is driven by...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...